{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:38:49Z","timestamp":1788183529992,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd014802","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000}}],"reference-count":85,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014802.pub2","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T08:39:46Z","timestamp":1741682386000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sulfonylurea drugs for people with severe hemispheric ischemic stroke"],"prefix":"10.1002","volume":"2025","author":[{"given":"Linlin","family":"Fan","sequence":"additional","affiliation":[{"name":"Neurocritical Care Unit, Department of Neurology; Xuanwu Hospital Capital Medical University; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[{"name":"Education Department; Capital Medical University Xuanwu Hospital; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Xuanwu Hospital Capital Medical University; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Evidence-based Medicine; Xuanwu Hospital Capital Medical University; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Xuanwu Hospital Capital Medical University; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuyang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Johns Hopkins University School of Medicine; Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD014802.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"104916","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104916","article-title":"Osmotherapy for malignant cerebral edema in a phase 2 prospective, double blind, randomized, placebo-controlled study of IV glibenclamide","volume":"29","author":"Hinson","year":"2020","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"23","key":"10.1002\/14651858.CD014802.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"e2163","DOI":"10.1212\/WNL.0000000000006618","article-title":"Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial","volume":"91","author":"Kimberly","year":"2018","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0003|cit3","unstructured":"Glyburide advantage in malignant edema and stroke \u2013 remedy pharmaceuticals (GAMES-RP) clinicaltrials.gov\/ct2\/show\/NCT01794182"},{"issue":"2","key":"10.1002\/14651858.CD014802.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"104488","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104488","article-title":"Poor outcomes related to anterior extension of large hemispheric infarction: topographic analysis of GAMES-RP trial MRI scans","volume":"29","author":"Payabvash","year":"2020","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD014802.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12028-015-0189-7","article-title":"Glyburide advantage in malignant edema and stroke (GAMES-RP) trial: rationale and design","volume":"24","author":"Sheth","year":"2016","journal-title":"Neurocritical Care"},{"issue":"11","key":"10.1002\/14651858.CD014802.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1474-4422(16)30196-X","article-title":"Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"15","author":"Sheth","year":"2016","journal-title":"Lancet Neurology"},{"issue":"6","key":"10.1002\/14651858.CD014802.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1161\/STROKEAHA.117.020365","article-title":"Long-term outcomes in patients aged \u2264 70 years with intravenous glyburide from the phase II GAMES-RP study of large hemispheric infarction: an exploratory analysis","volume":"49","author":"Sheth","year":"2018","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD014802.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1161\/STROKEAHA.119.026036","article-title":"Intravenous glibenclamide reduces lesional water uptake in large hemispheric infarction","volume":"50","author":"Vorasayan","year":"2019","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0009|cit9","unstructured":"Phase 3 study to evaluate the efficacy and safety of intravenous BIIB093 (glibenclamide) for severe cerebral edema following large hemispheric infarction (CHARM) clinicaltrials.gov\/ct2\/show\/NCT02864953"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014802.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"ATP20","DOI":"10.1161\/str.53.suppl_1.TP20","article-title":"Intravenous glibenclamide for large hemispheric infarction: baseline data from initial enrollees in the Charm Phase 3 study","volume":"53","author":"Sheth","year":"2022","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD014802.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12883-020-01823-z","article-title":"Safety and efficacy of glibenclamide combined with rtPA in acute cerebral ischemia with occlusion\/stenosis of anterior circulation (SE-GRACE): study protocol for a randomized controlled trial","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"102305","DOI":"10.1016\/j.eclinm.2023.102305","article-title":"Safety and efficacy of glibenclamide combined with rtPA in acute cerebral ischemia with occlusion\/stenosis of anterior circulation (SE-GRACE): a randomized, double-blind, placebo-controlled trial","volume":"65","author":"Huang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0013|cit13","unstructured":"Safety and efficacy of glibenclamide combined with Rt-PA in acute cerebral embolism (SE-GRACE) clinicaltrials.gov\/ct2\/show\/NCT03284463"},{"issue":"1514","key":"10.1002\/14651858.CD014802.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1098\/rstb.2008.0142","article-title":"Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator","volume":"364","author":"Aittoniemi","year":"2009","journal-title":"Philosophical Transactions of the Royal Society B: Biological Sciences"},{"issue":"7454","key":"10.1002\/14651858.CD014802.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD014802.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD014802.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00424-006-0116-z","article-title":"ABCC8 and ABCC9: ABC transporters that regulate K+ channels","volume":"453","author":"Bryan","year":"2007","journal-title":"Pfl\u00fcgers Archiv \u2013 European Journal of Physiology"},{"issue":"2","key":"10.1002\/14651858.CD014802.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/CIRCRESAHA.107.165324","article-title":"The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel","volume":"102","author":"Burke","year":"2008","journal-title":"Circulation Research"},{"issue":"3","key":"10.1002\/14651858.CD014802.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.3390\/ijms16034973","article-title":"Glibenclamide for the treatment of ischemic and hemorrhagic stroke","volume":"16","author":"Caffes","year":"2015","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1002\/14651858.CD014802.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12028-020-00959-7","article-title":"Guidelines for the acute treatment of cerebral edema in neurocritical care patients","volume":"32","author":"Cook","year":"2020","journal-title":"Neurocritical Care"},{"issue":"1","key":"10.1002\/14651858.CD014802.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001247.pub2","article-title":"Cooling therapy for acute stroke","author":"Den Hertog","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD014802.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/s-2007-979830","article-title":"Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide","volume":"28","author":"Draeger","year":"1996","journal-title":"Hormone and Metabolic Research"},{"issue":"10","key":"10.1002\/14651858.CD014802.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1507\/endocrj.EJ18-0493","article-title":"The differential influence of glimepiride and glibenclamide on insulin resistance and adiponectin levels in patients with type 2 diabetes","volume":"66","author":"Emini-Sadiku","year":"2019","journal-title":"Endocrine Journal"},{"issue":"9","key":"10.1002\/14651858.CD014802.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1111\/bcp.14774","article-title":"Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest: real-world data from a population-based study","volume":"87","author":"Eroglu","year":"2021","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD014802.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1161\/STROKEAHA.113.003200","article-title":"Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial","volume":"45","author":"Frank","year":"2014","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD014802.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1161\/STROKEAHA.113.002014","article-title":"Surgical decompression for space-occupying cerebral infarction: outcomes at 3 years in the randomized HAMLET trial","volume":"44","author":"Geurts","year":"2013","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD014802.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jdiacomp.2008.09.002","article-title":"Efficacy of glimepiride\/metformin combination versus glibenclamide\/metformin in patients with uncontrolled type 2 diabetes mellitus","volume":"23","author":"Gonz\u00e1lez-Ortiz","year":"2009","journal-title":"Journal of Diabetes and Its Complications"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0028|cit28","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2022"},{"issue":"1","key":"10.1002\/14651858.CD014802.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/epirev\/24.1.4","article-title":"Design of randomized trials","volume":"24","author":"Green","year":"2002","journal-title":"Epidemiologic Reviews"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.25259\/SNI_933_2020","article-title":"BIIB093 (intravenous glibenclamide) for the prevention of severe cerebral edema","volume":"12","author":"Griepp","year":"2021","journal-title":"Surgical Neurology International"},{"issue":"4","key":"10.1002\/14651858.CD014802.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/archneur.1996.00550040037012","article-title":"'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs","volume":"53","author":"Hacke","year":"1996","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD014802.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"R530","DOI":"10.1186\/cc3767","article-title":"Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200\/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial [ISRCTN62699180]","volume":"9","author":"Harutjunyan","year":"2005","journal-title":"Critical Care"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0033|cit33","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2\/"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0034|cit34","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"4","key":"10.1002\/14651858.CD014802.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1474-4422(09)70047-X","article-title":"Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial","volume":"8","author":"Hofmeijer","year":"2009","journal-title":"Lancet Neurology"},{"issue":"6","key":"10.1002\/14651858.CD014802.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/dmrr.235","article-title":"Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide","volume":"17","author":"Holstein","year":"2001","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"3","key":"10.1002\/14651858.CD014802.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/ane.13134","article-title":"Exploratory analysis of oral glibenclamide in acute ischemic stroke","volume":"140","author":"Huang","year":"2019","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3-4","key":"10.1002\/14651858.CD014802.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: the art of getting it wrong","volume":"1","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"issue":"9","key":"10.1002\/14651858.CD014802.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1161\/STROKEAHA.107.485649","article-title":"Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial","volume":"38","author":"J\u00fcttler","year":"2007","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD014802.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.diabres.2009.09.008","article-title":"Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study","volume":"86","author":"Khalangot","year":"2009","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.2147\/DDDT.S150043","article-title":"Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date","volume":"12","author":"King","year":"2018","journal-title":"Drug Design, Development and Therapy"},{"issue":"5","key":"10.1002\/14651858.CD014802.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1592\/phco.24.6.606.34752","article-title":"Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride","volume":"24","author":"Korytkowski","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD014802.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0005-2736(94)90178-3","article-title":"Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride","volume":"1191","author":"Kramer","year":"1994","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"10.1002\/14651858.CD014802.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1161\/STROKEAHA.107.482216","article-title":"Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke","volume":"38","author":"Kunte","year":"2007","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD014802.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ana.23680","article-title":"Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas","volume":"72","author":"Kunte","year":"2012","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD014802.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jphys.2013.12.012","article-title":"National Institute of Health stroke scale (NIHSS)","volume":"60","author":"Kwah","year":"2014","journal-title":"Journal of Physiotherapy"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"295906","DOI":"10.1155\/2012\/295906","article-title":"Application of mild therapeutic hypothermia on stroke: a systematic review and meta-analysis","volume":"2012","author":"Lakhan","year":"2012","journal-title":"Stroke Research and Treatment"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0048|cit48","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"1","key":"10.1002\/14651858.CD014802.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/pds.4337","article-title":"Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: a retrospective cohort study","volume":"27","author":"Leonard","year":"2018","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"3","key":"10.1002\/14651858.CD014802.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00424-013-1347-4","article-title":"TRPM4 inhibition promotes angiogenesis after ischemic stroke","volume":"466","author":"Loh","year":"2014","journal-title":"Pfl\u00fcgers Archiv \u2013 European Journal of Physiology"},{"issue":"3","key":"10.1002\/14651858.CD014802.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/s0149-2918(03)80109-1","article-title":"Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience","volume":"25","author":"Massi-Benedetti","year":"2003","journal-title":"Clinical Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD014802.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/NEN.0b013e3182a32e40","article-title":"Sulfonylurea receptor 1 expression in human cerebral infarcts","volume":"72","author":"Mehta","year":"2013","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"9128","key":"10.1002\/14651858.CD014802.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD014802.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0006-2952(94)90369-7","article-title":"Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade","volume":"48","author":"M\u00fcller","year":"1994","journal-title":"Biochemical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD014802.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jamaneurol.2018.4822","article-title":"Outcomes of hypothermia in addition to decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: a randomized clinical trial","volume":"76","author":"Neugebauer","year":"2019","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0074-7742(07)82021-6","article-title":"The blockade of K(+)-ATP channels has neuroprotective effects in an in vitro model of brain ischemia","volume":"82","author":"Nistic\u00f2","year":"2007","journal-title":"International Review of Neurobiology"},{"issue":"1","key":"10.1002\/14651858.CD014802.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.expneurol.2012.02.010","article-title":"ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats","volume":"235","author":"Ortega","year":"2012","journal-title":"Experimental Neurology"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD014802.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"1031\u201340","DOI":"10.1080\/13543784.2019.1681967","article-title":"BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema","volume":"28","author":"Pergakis","year":"2019","journal-title":"Expert Opinion on Investigation Drugs"},{"issue":"3","key":"10.1002\/14651858.CD014802.pub2-BIB0060|cit60","first-page":"141","article-title":"All-cause and cardiovascular mortality following treatment with metformin or glyburide in patients with type 2 diabetes mellitus","volume":"20","author":"Raee","year":"2017","journal-title":"Archives of Iranian Medicine"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0061|cit61","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"5","key":"10.1002\/14651858.CD014802.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jama.273.5.408","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD014802.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1161\/01.str.29.8.1550","article-title":"Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke","volume":"29","author":"Schwarz","year":"1998","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD014802.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/hs0102.100877","article-title":"Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke","volume":"33","author":"Schwarz","year":"2002","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0065|cit65","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"4","key":"10.1002\/14651858.CD014802.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nm1390","article-title":"Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke","volume":"12","author":"Simard","year":"2006","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1002\/14651858.CD014802.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/STROKEAHA.108.522409","article-title":"Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke","volume":"40","author":"Simard","year":"2009","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD014802.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/STROKEAHA.109.572644","article-title":"Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke","volume":"41","author":"Simard","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD014802.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12975-012-0149-x","article-title":"Glibenclamide-10-h treatment window in a clinically relevant model of stroke","volume":"3","author":"Simard","year":"2012","journal-title":"Translational Stroke Research"},{"issue":"6","key":"10.1002\/14651858.CD014802.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00424-012-1166-z","article-title":"Transient receptor potential melastatin 4 and cell death","volume":"464","author":"Simard","year":"2012","journal-title":"Pfl\u00fcgers Archiv \u2013 European Journal of Physiology"},{"issue":"9","key":"10.1002\/14651858.CD014802.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/jcbfm.2012.91","article-title":"Sulfonylurea receptor 1 in central nervous system injury: a focused review","volume":"32","author":"Simard","year":"2012","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD014802.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S2213-8587(14)70213-X","article-title":"Mortality risk among sulfonylureas: a systematic review and network meta-analysis","volume":"3","author":"Simpson","year":"2015","journal-title":"Lancet Diabetes & Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD014802.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/STROKEAHA.115.009789","article-title":"Improved neurological outcome with mild hypothermia in surviving patients with massive cerebral hemispheric infarction","volume":"47","author":"Su","year":"2016","journal-title":"Stroke"},{"issue":"15","key":"10.1002\/14651858.CD014802.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1745-6215-15-61","article-title":"An investigation of the impact of futility analysis in publicly funded trials","volume":"17","author":"Sully","year":"2014","journal-title":"Trials"},{"issue":"7","key":"10.1002\/14651858.CD014802.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/01616412.2021.1893563","article-title":"Health-related quality of life after ischemic stroke: impact of sociodemographic and clinical factors","volume":"43","author":"Tsalta-Mladenov","year":"2021","journal-title":"Neurological Research"},{"issue":"4","key":"10.1002\/14651858.CD014802.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.10.019","article-title":"Sulfonylurea pretreatment and in-hospital use does not impact acute ischemic strokes (AIS) outcomes following intravenous thrombolysis","volume":"26","author":"Tsivgoulis","year":"2017","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"9","key":"10.1002\/14651858.CD014802.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1161\/STROKEAHA.107.485235","article-title":"Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial)","volume":"38","author":"Vahedi","year":"2007","journal-title":"Stroke"},{"issue":"Pt 12","key":"10.1002\/14651858.CD014802.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1093\/brain\/awm083","article-title":"Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis","volume":"130","author":"Worp","year":"2007","journal-title":"Brain"},{"issue":"11","key":"10.1002\/14651858.CD014802.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1161\/STROKEAHA.119.026036","article-title":"Intravenous glibenclamide reduces lesional water uptake in large hemispheric infarction","volume":"50","author":"Vorasayan","year":"2019","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD014802.pub2-BIB0080|cit80","unstructured":"World Health Organization (WHO) The top 10 causes of death; December 2020 Available from www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death"},{"issue":"5","key":"10.1002\/14651858.CD014802.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1074\/jbc.M112.428219","article-title":"The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel","volume":"288","author":"Woo","year":"2013","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1002\/14651858.CD014802.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.diabres.2009.12.010","article-title":"Effects of glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus","volume":"88","author":"Du","year":"2010","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"6","key":"10.1002\/14651858.CD014802.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.yjmcc.2004.11.020","article-title":"Neuroprotection by KATP channels","volume":"38","author":"Yamada","year":"2005","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD014802.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12028-012-9703-3","article-title":"Decompressive hemicraniectomy in malignant middle cerebral artery infarct: a randomized controlled trial enrolling patients up to 80 years old","volume":"17","author":"Zhao","year":"2012","journal-title":"Neurocritical Care"},{"issue":"6","key":"10.1002\/14651858.CD014802.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014802","article-title":"Neuroprotective effect of sulfonylurea drugs for people with ischemic stroke","author":"Fan","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:02:18Z","timestamp":1787922138000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014802.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":85,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014802.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]}}}